Please assess the completion status of the following clinical trial:

Trial Title: Beat the Blues in Pregnancy Study - Transcranial Magnetic Stimulation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects are capable of giving written informed consent and complying with all study procedures;~* Female age 18-39 years old at date of enrollment;~* Pregnant, weeks 14-34;~* Current Depressive Symptoms;~* No change in antidepressant medication at least two weeks prior to study entry if using an antidepressant.~Exclusion Criteria:~* Any alcohol or drug abuse/dependence over the 6 months prior to study entry;~* History of a seizure disorder in subject or first degree relative;~* Anti-psychotic, lithium, or anti-convulsant medications within 2 weeks of study enrollment;~* History of known brain lesions, or severe head trauma;~* Subjects with any metallic object implanted in the skull;~* Subjects with significant cardiac disease;~* Neurological or psychiatric disorders;~* Serious medical illnesses that may compromise patient safety or study conduct;~* Currently taking a drug with known potential for fetal toxicity;~* Previous pregnancy with an adverse fetal outcome;~* Current obstetrical complications~* Actively suicidal;~* History of depression unresponsive to treatment with electroconvulsive therapy (ECT).

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 39 Years
- Healthy Volunteers: f

Study Arms:
- Active Transcranial Magnetic Stimulation (Type: ACTIVE_COMPARATOR): 38 pregnant women with MDD will be randomized to receive active 1 Hz right-sided dorsolateral prefrontal cortex (DLPFC) TMS.
- Sham Transcranial Magnetic Stimulation (Type: SHAM_COMPARATOR): 38 pregnant women with MDD will be randomized to receive sham transcranial magnetic stimulation.

Based on this trial design, predict the completion outcome and termination type (if applicable).